Delivery Order SPE2DB22D2211-SPE2DB24FMCW1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,807.92 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a period of performance through December 5, 2023, and was awarded on December 4, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX5BB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,411.47 firm fixed-price delivery order is for 4562749917 - LIDOCAINE 5% PATCH 30S, with a completion date of November 8, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.76 firm fixed-price contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a performance period through May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order valued at $1,202.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for 4559509218 - LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2023 and was awarded on January 5, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,157.46 firm fixed-price delivery order is for LIDOCAINE 5% PATCH 30S, a medical product, with a performance period through January 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,657.50 firm-fixed price delivery order is for the supply of 4564559510 LIDOCAINE 5% PATCH 30S. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $1,554.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) to provide LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the DLA. The contract has a period of performance ending on February 6, 2024 and is a Firm Fixed Price (FFP) agreement. There is no set-aside designation for this award, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $6,680.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, valued at $1,769.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also a for-profit organization. The contract is a Delivery Order under an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,925.80 delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a completion date of May 19, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMCW1Delivery Order
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,861.76 fixed-price contract is for the delivery of 4562764766 - LIDOCAINE 5% PATCH 30S, with a period of performance through November 9, 2023. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA and Department of Justice. The company holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, as well as a separate $750,000 contract with the Department of Justice Federal Bureau of Investigation, which provide a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/8/23 |